FDA Clearance Tracker · P030016-S045
EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),
Last checked: Nov 20, 2026Latest source record: Oct 1, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 1, 2024
Approved
Time to decision
172 days
Received Apr 12, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030016-S045
- Device name
- EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- Apr 12, 2024
- Decided
- Oct 1, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030016
Device type
- Device type
- Lens, intraocular, phakic (MTA)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for labeling updates related to PAS CP22-01 Postmarket Evaluation of the EVO ICL"
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
- Visian Toric ICL (IMPLANTABLE COLLAMER LENS)PMA supplement
P030016-S001 · Decided Sep 13, 2018 · 4,521 days after receipt · Panel Track
Device type: Phakic toric intraocular lens (QCB) · Ophthalmology
K172375 · Decided Sep 6, 2017 · 30 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.